Shire Global Value Strategy Lead, Genetic Diseases in Zug, Switzerland

Primary Duties

Provide a single point of contact for all market access issues and activities for assigned product/s. Lead the coordination of market access initiatives for the product/s across all regions ensuring seamless global to local integration and delivery.

Responsibilities

  • Lead the identification and prioritization of strategic opportunities to enhance and expand product value proposition (payers, prescribers, patients, and policymakers) for product/s, including life cycle management opportunities. Collaborate with relevant colleagues across Shire and in assigned Early Stage Global Product Teams (ELT) and / or Late Stage Global Product Teams (LPT) to successfully address such opportunities.

  • Provide expertise in market access with an understanding of the role and influence of market access in product development and lifecycle management.

  • Identify future trends in market access and develop strategic initiatives within GVSA, across the Global Value Team and Shire to ensure the strategy for the product/s are adapted to maximize the commercial success of the product.

  • Understand and apply the payer-relevant outcomes as it applies to specific therapeutic classes.

  • Proactively address product/s related payer, HTA and policymaker demands and respond to emerging or unforeseen market opportunities/challenges.

For designated brands / products:

  • Serve as primary contact ‘one voice’ responsible for all product interactions within respective Business Development/Due Diligence team/s, Early Stage Global Product Teams (ELT) and / or Late Stage Global Product Teams (LPT).

  • Lead the development of the global value proposition working within GVSA and leading the cross functional Global Value Team.

  • Ensure the development, delivery and maintenance of the global value proposition , global market access strategy, supportive market access evidence, global value dossier, and global pricing strategy through a products development and lifecycle.

  • Work with GVSA Franchise Lead and GVSA LT for alignment of product/s strategy to the Shire portfolio and GPS strategy.

  • Represent the product /s within GVSA ensuring alignment of strategy and operations resulting in delivery of outputs and resource to meet the needs of the product/s and BD/Pipeline/BU.

  • Lead and coordinate GVSA teams (e.g. US PMA / International VD&A) to support the development of market access elements for the product/s.

  • Work with International VD&A and US P&MA teams to provide insights and requirements for the product/s ensuring their input is gained for strategy development from these respective geographies and areas of expertise and also they have adequate resource and capabilities to provide GVSA deliverables.

  • Lead training of Global Value Proposition, associated Core Value Dossier (CVD) and underlying clinical, economic and quality of life evidence with marketing teams and other key internal stakeholders.

  • Take a key role in interactions with external stakeholders to advocate the value of product/s.

Education and Experience

  • University degree required, advanced degree in related field (e.g., MBA, MPH, MPA, PharmD) preferred

  • 10 or more years of market access experience with solid track record in developing pricing, reimbursement and access (PR&A) strategies and influencing PR&A negotiations in relevant geographic markets

  • University degree required, advanced degree in related field (e.g., MBA, MPH, MPA, PharmD) preferred

  • 10 or more years of market access experience with solid track record in developing pricing, reimbursement and access (PR&A) strategies and influencing PR&A negotiations in relevant geographic markets

  • Experience collaborating with marketing/sales teams on appropriate pull-through strategies

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal/Internal Medicine/Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.